Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
Sales | 11,985,000 | 11,624,000 | 11,703,000 | 11,073,000 | 11,068,000 |
Cost of Goods | 2,356,000 | 2,291,000 | 2,452,000 | 2,841,000 | 2,910,000 |
Gross Profit | 9,629,000 | 9,333,000 | 9,251,000 | 8,232,000 | 8,158,000 |
Operating Expenses | 7,771,000 | 7,176,000 | 7,698,000 | 5,702,000 | 18,609,000 |
Operating Income | 1,858,000 | 2,157,000 | 1,553,000 | 2,530,000 | -10,451,000 |
Pre-tax Income | 1,858,000 | 2,157,000 | 1,553,000 | 2,530,000 | -10,451,000 |
Income Tax | -514,000 | 605,000 | 492,000 | 501,000 | -424,000 |
Net Income Continuous | 2,372,000 | 1,552,000 | 1,061,000 | 2,029,000 | -10,027,000 |
Minority Interests | N/A | 6,000 | 6,000 | 8,000 | N/A |
Net Income | $2,372,000 | $1,546,000 | $1,055,000 | $2,021,000 | $-10,027,000 |
EPS Basic Total Ops | 1.08 | 0.70 | 0.47 | 0.90 | -4.44 |
EPS Basic Continuous Ops | 1.07 | 0.70 | 0.48 | 0.91 | -4.44 |
EPS Diluted Total Ops | 1.07 | 0.69 | 0.47 | 0.89 | -4.43 |
EPS Diluted Continuous Ops | 1.07 | 0.69 | 0.47 | 0.90 | -4.43 |
EBITDA(a) | $4,437,000 | $4,884,000 | $4,265,000 | $5,198,000 | $-7,761,000 |